Yuliya Lokhnygina - Concepedia

Author

Yuliya Lokhnygina

Also Known As

Amamoo, M. Ahinee, Andrea Cromer, Aschner, Pablo, CDC Prevention Epicenters Program, Fowler, Vance G., Green, Jennifer B., Jones W.S, Lokhnygina, Yuliya, Melissa Elder, Unroe, Kathleen Tschantz

295

Publications

15.7K

Citations

H-Index

155

Concepts

All Affiliations

Clinical Research Institute Duke University Duke Medical Center Harvard University Stanford University

About

Yuliya Lokhnygina is an author at Clinical Research Institute specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	51	4K
2	Health Sciences	5	5	662
3	Engineering	4	4	222
4	Natural Sciences	1	1	69
5	Nursing	1	1	37

Yuliya Lokhnygina

126

Publications

14K

Citations

H-Index

Page 1

	Year	Citations
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes Rury R. Holman, M. Angelyn Bethel, Robert J. Mentz, New England Journal of Medicine	2017	2.1K
Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization Matthew T. Roe, Paul W. Armstrong, Keith A.A. Fox, New England Journal of Medicine	2012	859
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes Pierluigi Tricoci, Zhen Huang, Claes Held, New England Journal of Medicine	2011	747
Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation Jonathan P. Piccini, Susanna R. Stevens, Yuchiao Chang, Circulation	2012	494
Relation between Dose of Loop Diuretics and Outcomes in a Heart Failure Population: Results of the ESCAPE Trial Vic Hasselblad, Wendy Gattis Stough, Monica Shah, European Journal of Heart Failure	2007	440
Efficacy and Safety of Rivaroxaban Compared With Warfarin Among Elderly Patients With Nonvalvular Atrial Fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF) Jonathan L. Halperin, Graeme J. Hankey, Daniel Wojdyla, Circulation	2014	427
Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial Benjamin A. Steinberg, Anne S. Hellkamp, Yuliya Lokhnygina, European Heart Journal	2014	350
Enhanced terminal room disinfection and acquisition and infection caused by multidrug-resistant organisms and Clostridium difficile (the Benefits of Enhanced Terminal Room Disinfection study): a cluster-randomised, multicentre, crossover study Deverick J. Anderson, Luke F. Chen, David J. Weber, The Lancet Antimicrobial SusceptibilityHealth SciencesAntibioticsClostridium DifficileHealthcare-associated Infection	2017	338
Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial Marco Valgimigli, Francesco Costa, Yuliya Lokhnygina, European Heart Journal	2016	323
A Polymorphism Near IL28B Is Associated With Spontaneous Clearance of Acute Hepatitis C Virus and Jaundice Hans L. Tillmann, A. Thompson, Keyur Patel, Gastroenterology Il28b Is AssociatedAutoimmune DiseaseHepatitis CHepatologyViral Hepatitis	2010	319

Page 1